CLOV vs IMA
Clover Health Investments Corp (CLOV) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
CLOV currently screens at market cap $1.55B. IMA currently screens at market cap $64.7M.
Not investment advice. Open the CLOV and IMA stock pages for the full models.
Not investment advice.